Virology, Emerging Diseases & Vaccines

Welcome Message

Final Abstract Submission Deadline: 28th March 2024

Join us in Rome, Italy, on May 16-17, 2024, for the 19th World Congress on Virology, Emerging Diseases & Vaccines. Themed "Advancing Global Health through Vaccination," our conference aims to foster collaboration and innovation among experts in virology, infectious diseases, and vaccination to address urgent viral disease challenges.

Lead the way in innovation by securing your registration and submitting your abstract to this momentous virology conference, as the official countdown has started!

Sessions & Tracks

Session 1. Basic Virology

Session 2. Clinical Virology

Session 3. Viral Pathogenesis

Session 4. Viral Genomics and Bioinformatics

Session 5. Viral Ecology and Evolution

Session 6. Viral Vaccines and Immunology

Session 7. Public Health and Epidemiology

Session 8. Therapeutics and Antiviral Agents

Session 9. Viral Diagnostics and Laboratory Techniques

Session 10.  One Health Approaches to Virology

Why to Attend/ Sponsor/ Exhibitor

The 19th World Congress on Virology, Emerging Diseases & Vaccines is a unique and exciting opportunity, have been designed in an interdisciplinary manner with a multitude of tracks to showcase the new technology, the new products of your company, the service your industry may offer to a broad international audience. It covers a lot of topics and it will be a nice platform to showcase their recent research on Virology Applications.

Business networking is an avenue for vendors to have network and B2B meetings with “Top Scientists and Colleagues” and with an effective low-cost marketing method for developing sales and opportunities and contacts, based on referrals and introductions either face-to-face at meetings and gatherings, or by other contact methods such as Telephone, E mail, Digital and increasingly social and business networking websites.

Your sponsorship/exhibition will give your organization fantastic exposure to around 150 attendees, and offers a unique opportunity to align your brand with this very highly successful, high profile event.

Virology 2024 will provide a terrific and diverse platform to interact and network with fellow industry colleagues.
 

2024 Highlights:

• 150 Participation (70 Industry: 30 Academia)
• 10+ Keynote Speakers
• 50+ Plenary Speakers
• 05+ Exhibitors
• 12 Innovative Educational Sessions
• 5+ Workshops

Benefits of Attending

• To foster discussions, share expertise and exchange knowledge and best practices at all levels of the healthcare spectrum
• To encourage collaboration and enhance interactions at a global level
• Meet a range of specialists actively practicing in the field
• Strengthen your profile and position your organization as a key industry figure
• Develop new partnerships and networks with key decision makers/influencers
• Open doors for your organization to connect and develop strategic relationships in a neutral and relaxed sales environment
• Get access to targeted audience
• Brand Exposure – Promote your company’s message, products and services through a national Conference marketing campaign
• First hand live demonstrations to delegates
• To showcase new healthcare technologies and solutions in an intimate setting focused specifically on microbiology.

Targeted Audience

• Directors, CEO’s of Organizations
• Business Development Managers
• Chief Scientific Officers
• R&D Researchers from Pharma Industries
• Professors, Associate Professors, Assistant Professors
• PhD Scholars
• Association, Association presidents and professionals
• Noble laureates in Health Care and Medicine
• Research Institutes and members
• Manufacturing Companies
• Training Institutes

Market Analysis

"Global Virology Testing Market: Industry Trends and 2029 Forecast"

The global virology testing market encompasses a wide array of procedures, diagnosis tests, methods, and applications. These include the Cell Culture Method, Specific Antibodies Detection, Antigen Detection, Virus Nucleic Acid Detection, Gene Sequencing, and Hemagglutination Assays as procedures. Diagnosis tests cover Hepatitis B, Hepatitis C, HIV, Human Papillomavirus (HPV), and other tests. Methods employed consist of Immunoprophylaxis, Active Prophylaxis (Vaccines), Passive Prophylaxis, Antiviral Chemotherapy, and Interferon's (Cytokines). Read more...

Past Conference Report

In 2023, the "18th World Congress on Virology, Emerging Diseases & Vaccines" held in Amsterdam, Netherlands, was a resounding success under the theme "Immunization is the Key to Fight Pathogens." Esteemed speakers from prestigious institutions shared insights. The conference featured scientific sessions, plenary lectures, and we extend gratitude to all guests and speakers.

Notably, Aysun Yilmaz, Nahla Mohamed, Huseyin Yilmaz, Sabiha Imran, Ahmad Alshehri, Meshal Beidas, and Nuri Turan delivered outstanding presentations, enriching attendees' knowledge.

Special thanks to conference moderator Alfredo Berzal-Herranz. The Organizing Committee, Keynote Speakers, Chairs, Co-Chairs, Young Researchers, and attendees played a pivotal role in the conference's success.

The conference showcased interdisciplinary chemistry trends and technical advancements.

Join us at the "18th World Congress on Virology, Emerging Diseases & Vaccines" on February 01-02, 2024, in Dubai, UAE, with the theme "Advancing Global Health through Vaccination." It offers a platform for networking, innovation sharing, and research presentation.

We invite you to participate as International Organizing Committee Members, Speakers, Keynote Speakers, Sponsors, and more. Expect engaging sessions on Antiviral Therapeutics, Bioinformatics, Clinical Trials, and more.

We anticipate your presence at Virology 2024, building on Virology 2023's success.